Defunct Company
Total Trials
14
As Lead Sponsor
13
As Collaborator
1
Total Enrollment
5,858
NCT00142545
"Long Term Safety and Efficacy of SC Apomorphine in Treatment of Off Episodes in Late-Stage Parkinson's Disease"
Phase: Phase 3
Role: Lead Sponsor
Start: Jul 31, 1999
Completion: Jul 31, 2005
NCT00200512
Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months
Phase: Phase 2/3
Start: Sep 30, 1999
Completion: Nov 30, 1999
NCT00145171
A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.
Start: Feb 28, 2001
Completion: Aug 31, 2002
NCT00200525
Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease
Start: Jul 31, 2001
Completion: Jun 30, 2002
NCT00200460
A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients
Start: Sep 30, 2001
Completion: Mar 31, 2003
NCT00200473
A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients
NCT00145236
Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension
Start: Nov 30, 2001
Completion: Aug 31, 2003
NCT00200499
A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients
Start: Mar 31, 2002
Completion: Sep 30, 2003
NCT00200421
A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension
Phase: Phase 2
Start: May 31, 2002
NCT00200434
A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension
Start: Oct 31, 2002
Completion: Oct 31, 2003
NCT00158093
A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo
Phase: Phase 1
Start: Jun 30, 2003
Completion: Jul 31, 2003
NCT00145210
Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans
Start: Apr 30, 2005
Completion: Sep 30, 2007
NCT00142584
Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension
Start: Aug 31, 2005
Completion: Mar 31, 2008
NCT00634166
Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
Phase: Phase 4
Role: Collaborator
Start: Sep 30, 2007
Completion: Apr 30, 2014